Epigral Limited has announced its unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026. The company reported a profit after tax of ₹64.42 crore for the standalone Q2 FY27 and ₹65.08 crore for the consolidated Q2 FY27. For the half year ended September 30, 2026, the standalone profit after tax stood at ₹163.60 crore, and the consolidated profit after tax was ₹164.82 crore.
Epigral Limited Announces Q2 and H1 FY27 Financial Highlights
Epigral Limited has officially disclosed its unaudited financial results for the second quarter and the first half of the financial year 2027, concluding on September 30, 2026. The company’s Board of Directors reviewed and approved these results, which were presented following a board meeting held on November 2, 2026.
Standalone Financial Performance
For the second quarter ended September 30, 2026, Epigral Limited reported a standalone profit after tax of ₹64.42 crore. The total comprehensive income for the same period was also ₹64.42 crore. Looking at the first half of FY27, the standalone profit after tax reached ₹163.60 crore, with total comprehensive income mirroring this figure.
Consolidated Financial Performance
On a consolidated basis, Epigral Limited announced a profit after tax of ₹65.08 crore for the second quarter ended September 30, 2026. The total comprehensive income for the quarter was ₹65.08 crore. For the half year ended September 30, 2026, the consolidated profit after tax was reported as ₹164.82 crore, with total comprehensive income standing at ₹164.83 crore.
Key Financial Metrics
Revenue from operations for the standalone Q2 FY27 was ₹745.99 crore, contributing to a total income of ₹751.81 crore. Total expenses for the quarter amounted to ₹664.89 crore. The standalone balance sheet as of September 30, 2026, shows total assets of ₹3,584.14 crore and total equity and liabilities of the same amount.
Other Disclosures
The company also provided earnings per share data. For the standalone Q2 FY27, basic and diluted earnings per share were ₹14.93. The financial results were accompanied by a Limited Review Report from M/s. S R B C & CO LLP, Statutory Auditors.
Source: BSE
